SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-23-000064
Filing Date
2023-01-11
Accepted
2023-01-11 16:37:08
Documents
16
Period of Report
2023-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 33582
2 PRESS RELEASE ex99x1.htm EX-99.1 10172
3 PRESS RELEASE ex99x2.htm EX-99.2 10129
4 GRAPHIC image_002.jpg GRAPHIC 4260
5 GRAPHIC image_001.jpg GRAPHIC 4260
  Complete submission text file 0001079973-23-000064.txt   252083

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE opgn-20230106.xsd EX-101.SCH 3218
7 XBRL LABEL FILE opgn-20230106_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE opgn-20230106_pre.xml EX-101.PRE 22353
10 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3563
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 23523989
SIC: 8071 Services-Medical Laboratories